Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
type 1 diabetes
adaptive biotechnologies
alector
allergan
amgen
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer drugs
civica rx
deals
detroit blog main
detroit top stories
diabets
drug prices
elijah cummings
empagliflozin
europe
europe blog main
europe top stories
genentech
What
diabetes
2
×
eli
2
×
appetite
approval
bid
bio
black
boehringer
bread
butter
buyout
cancer
cash
diamond’s
drug
drugs
expand
fallen
fda
giant
grabbed
hasn’t
hold
ingelheim
lilly
lilly's
lost
loxo
marketed
medicine’s
notes
patients
pharmaceutical
rejects
roundup
short
type
Language
unset
Current search:
eli
×
diabetes
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
